Cite
Fuchs JD, Bart PA, Frahm N, et al. Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. J AIDS Clin Res. 2015;6(5)doi: 10.4172/2155-6113.1000461.
Fuchs, J. D., Bart, P. A., Frahm, N., Morgan, C., Gilbert, P. B., Kochar, N., DeRosa, S. C., Tomaras, G. D., Wagner, T. M., Baden, L. R., Koblin, B. A., Rouphael, N. G., Kalams, S. A., Keefer, M. C., Goepfert, P. A., Sobieszczyk, M. E., Mayer, K. H., Swann, E., Liao, H. X., Haynes, B. F., Graham, B. S., McElrath, M. J. (2015). Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. Journal of AIDS & clinical research, 6(5), . https://doi.org/10.4172/2155-6113.1000461
Fuchs, Jonathan D, et al. "Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals." Journal of AIDS & clinical research vol. 6,5 (2015). doi: https://doi.org/10.4172/2155-6113.1000461
Fuchs JD, Bart PA, Frahm N, Morgan C, Gilbert PB, Kochar N, DeRosa SC, Tomaras GD, Wagner TM, Baden LR, Koblin BA, Rouphael NG, Kalams SA, Keefer MC, Goepfert PA, Sobieszczyk ME, Mayer KH, Swann E, Liao HX, Haynes BF, Graham BS, McElrath MJ. Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. J AIDS Clin Res. 2015 May;6(5). doi: 10.4172/2155-6113.1000461. Epub 2015 May 23. PMID: 26587311; PMCID: PMC4648371.
Copy
Download .nbib